Form 8-K - Current report:
SEC Accession No. 0001493152-24-040974
Filing Date
2024-10-15
Accepted
2024-10-11 18:25:22
Documents
16
Period of Report
2024-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52533
2 ex1-1.htm EX-1.1 294282
3 ex5-1.htm EX-5.1 14978
4 ex5-1_001.jpg GRAPHIC 28445
  Complete submission text file 0001493152-24-040974.txt   645518

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ogen-20241011.xsd EX-101.SCH 3018
6 XBRL LABEL FILE ogen-20241011_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ogen-20241011_pre.xml EX-101.PRE 24167
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3699
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241368674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)